As semiconductor large caps' concentration eases and deleveraging concludes, rotation from KOSPI to KOSDAQ, biotech, and growth stocks intensifies in a rotational trading market that separates quality from junk.
Core macro narrative repeated throughout the 7-day window. Peaked with KOSDAQ surging 6.97% on 08-10 and triggering circuit breakers 4 times; public interest at peak today with news of 'KOSDAQ rallying again' and 'biotech biggest beneficiary.'
View analysis
Why it matters
Reports (multiple from Daishin, Shinhan, Kiwoom) and news (KOSDAQ surge, biotech rotation) simultaneously intensified; consensus-driven dominant narrative.
What would change it
KOSDAQ surge from short-term margin buying and speculative inflows merely recreates volatility with limited sustainability.
Korea exposure
No stock names are recorded for this observation.
Observed evidence · 12 research notes · 487 news mentions
N/A